Search research articles
Contact Us
Filters
Showing results (41-50 of 62) with videos related to
Page
of 7
Sort By:
Proceedings of the National Academy of Sciences of the United States of America
|
April 7, 2011
Immunization with HIV Gag targeted to dendritic cells followed by recombinant New York vaccinia virus induces robust T-cell immunity in nonhuman primates
Barbara J Flynn, Kathrin Kastenmüller, Ulrike Wille-Reece, et al.
Journal of Virology
|
August 26, 2011
The HIV/AIDS vaccine candidate MVA-B administered as a single immunogen in humans triggers robust, polyfunctional, and selective effector memory T cell responses to HIV-1 antigens
Carmen Elena Gómez, José Luis Nájera, Beatriz Perdiguero, et al.
Frontiers in Immunology
|
December 24, 2019
The Envelope-Based Fusion Antigen GP120C14K Forming Hexamer-Like Structures Triggers T Cell and Neutralizing Antibody Responses Against HIV-1
Suresh C Raman, Ernesto Mejías-Pérez, Carmen E Gomez, et al.
Journal of Virology
|
October 31, 2014
Virological and immunological characterization of novel NYVAC-based HIV/AIDS vaccine candidates expressing clade C trimeric soluble gp140(ZM96) and Gag(ZM96)-Pol-Nef(CN54) as virus-like particles
Beatriz Perdiguero, Carmen Elena Gómez, Victoria Cepeda, et al.
Plos One
|
April 11, 2018
Correction: Safety and vaccine-induced HIV-1 immune responses in healthy volunteers following a late MVA-B boost 4 years after the last immunization
Alberto C Guardo, Carmen Elena Gómez, Vicens Díaz-Brito, et al.
Plos One
|
October 25, 2017
Safety and vaccine-induced HIV-1 immune responses in healthy volunteers following a late MVA-B boost 4 years after the last immunization
Alberto C Guardo, Carmen Elena Gómez, Vicens Díaz-Brito, et al.
Plos One
|
April 27, 2012
Systems analysis of MVA-C induced immune response reveals its significance as a vaccine candidate against HIV/AIDS of clade C
Carmen Elena Gómez, Beatriz Perdiguero, Victoria Jiménez, et al.
Plos One
|
February 25, 2011
Improved innate and adaptive immunostimulation by genetically modified HIV-1 protein expressing NYVAC vectors
Esther D Quakkelaar, Anke Redeker, Elias K Haddad, et al.
NPJ Vaccines
|
March 6, 2024
Modulating the immune response to SARS-CoV-2 by different nanocarriers delivering an mRNA expressing trimeric RBD of the spike protein: COVARNA Consortium
Laura Marcos-Villar, Beatriz Perdiguero, Shubaash Anthiya, et al.
NPJ Vaccines
|
May 18, 2024
Author Correction: Modulating the immune response to SARS-CoV-2 by different nanocarriers delivering an mRNA expressing trimeric RBD of the spike protein: COVARNA Consortium
Laura Marcos-Villar, Beatriz Perdiguero, Shubaash Anthiya, et al.
Page
of 7
Search research articles
Search
Showing results (41-50 of 62) with videos related to
Sort By:
Page
of 7
Proceedings of the National Academy of Sciences of the United States of America
|
April 7, 2011
Immunization with HIV Gag targeted to dendritic cells followed by recombinant New York vaccinia virus induces robust T-cell immunity in nonhuman primates
Barbara J Flynn, Kathrin Kastenmüller, Ulrike Wille-Reece, et al.
Journal of Virology
|
August 26, 2011
The HIV/AIDS vaccine candidate MVA-B administered as a single immunogen in humans triggers robust, polyfunctional, and selective effector memory T cell responses to HIV-1 antigens
Carmen Elena Gómez, José Luis Nájera, Beatriz Perdiguero, et al.
Frontiers in Immunology
|
December 24, 2019
The Envelope-Based Fusion Antigen GP120C14K Forming Hexamer-Like Structures Triggers T Cell and Neutralizing Antibody Responses Against HIV-1
Suresh C Raman, Ernesto Mejías-Pérez, Carmen E Gomez, et al.
Journal of Virology
|
October 31, 2014
Virological and immunological characterization of novel NYVAC-based HIV/AIDS vaccine candidates expressing clade C trimeric soluble gp140(ZM96) and Gag(ZM96)-Pol-Nef(CN54) as virus-like particles
Beatriz Perdiguero, Carmen Elena Gómez, Victoria Cepeda, et al.
Plos One
|
April 11, 2018
Correction: Safety and vaccine-induced HIV-1 immune responses in healthy volunteers following a late MVA-B boost 4 years after the last immunization
Alberto C Guardo, Carmen Elena Gómez, Vicens Díaz-Brito, et al.
Plos One
|
October 25, 2017
Safety and vaccine-induced HIV-1 immune responses in healthy volunteers following a late MVA-B boost 4 years after the last immunization
Alberto C Guardo, Carmen Elena Gómez, Vicens Díaz-Brito, et al.
Plos One
|
April 27, 2012
Systems analysis of MVA-C induced immune response reveals its significance as a vaccine candidate against HIV/AIDS of clade C
Carmen Elena Gómez, Beatriz Perdiguero, Victoria Jiménez, et al.
Plos One
|
February 25, 2011
Improved innate and adaptive immunostimulation by genetically modified HIV-1 protein expressing NYVAC vectors
Esther D Quakkelaar, Anke Redeker, Elias K Haddad, et al.
NPJ Vaccines
|
March 6, 2024
Modulating the immune response to SARS-CoV-2 by different nanocarriers delivering an mRNA expressing trimeric RBD of the spike protein: COVARNA Consortium
Laura Marcos-Villar, Beatriz Perdiguero, Shubaash Anthiya, et al.
NPJ Vaccines
|
May 18, 2024
Author Correction: Modulating the immune response to SARS-CoV-2 by different nanocarriers delivering an mRNA expressing trimeric RBD of the spike protein: COVARNA Consortium
Laura Marcos-Villar, Beatriz Perdiguero, Shubaash Anthiya, et al.
Page
of 7